Balentine LLC’s Cohen & Steers CNS Stock Holding History

Balentine LLC’s Portfolio CNS Stock Details CNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-60	Closed	-$3K	–	157
2017 Q4	$3K	Hold	60	–	–	﹤0.01%	559
2017 Q3	$2K	Hold	60	–	–	﹤0.01%	600
2017 Q2	$2K	Hold	60	–	–	﹤0.01%	571
2017 Q1	$2K	Buy	+60	New	+$2.17K	﹤0.01%	542

Other funds holding CNS

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GTP

Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Balentine LLC's CNS Position: Q1 2018 in Review

Balentine LLC sold out of Cohen & Steers (CNS) in Q1 2018, closing a stake of 60 shares — an estimated $3K sold.

Balentine LLC first reported a position in CNS in Q1 2017 and held it in 4 quarters. The position peaked at $3K in Q4 2017. 149 funds tracked by Wall St. Rank hold CNS as of Q1 2018.

Balentine LLC reported no remaining Cohen & Steers position as of Q1 2018 after selling out during the quarter.
Balentine LLC sold 60 Cohen & Steers shares in Q1 2018, an estimated $3K.
Balentine LLC first reported a position in Cohen & Steers in Q1 2017 and held it in 4 quarters.
Balentine LLC's Cohen & Steers position peaked at $3K in Q4 2017.
149 funds tracked by Wall St. Rank held Cohen & Steers as of Q1 2018.

Based on Balentine LLC's 13F filing for Q1 2018, filed 16 May 2018.